Director David Hsu Reports No Securities Ownership in Anbio Biotechnology

This SEC Form 3 filing reports that David Hsu, a director of Anbio Biotechnology (ticker: NNNN), has no securities ownership in the company as of March 18, 2026. The filing was signed on June 12, 2026, and indicates that Mr. Hsu, who is based in Frankfurt, Germany, holds a director position but does not own any shares or securities of the company. Form 3 is an initial statement of beneficial ownership of securities required for company insiders, directors, and officers. The filing confirms that despite his director role, Mr. Hsu has no current ownership stake in Anbio Biotechnology, which provides transparency about insider holdings for regulatory compliance and investor information purposes.